Versant Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14
| Closed | -$506 | – | 2095 |
|
|
2023
Q2 | $506 | Buy |
14
+9
| +180% | +$325 | ﹤0.01% | 1833 |
|
|
2023
Q1 | $186 | Sell |
5
-14
| -74% | -$521 | ﹤0.01% | 1726 |
|
|
2022
Q4 | $861 | Sell |
19
-34
| -64% | -$1.54K | ﹤0.01% | 1328 |
|
|
2022
Q3 | $4K | Buy |
53
+29
| +121% | +$2.19K | ﹤0.01% | 938 |
|
|
2022
Q2 | $2K | Buy |
+24
| New | +$2K | ﹤0.01% | 1175 |
|
|
2022
Q1 | – | Sell |
-59
| Closed | -$9K | – | 1680 |
|
|
2021
Q4 | $9K | Hold |
59
| – | – | ﹤0.01% | 742 |
|
|
2021
Q3 | $10K | Buy |
59
+55
| +1,375% | +$9.32K | ﹤0.01% | 710 |
|
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1403 |
|
|
2021
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 1476 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$1K | – | 1774 |
|
|
2019
Q4 | $1K | Sell |
9
-3
| -25% | -$333 | ﹤0.01% | 1303 |
|
|
2019
Q3 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1654 |
|
|
2019
Q2 | – | Sell |
-4
| Closed | – | – | 1777 |
|
|
2019
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1782 |
|